Enterprises – Facing the XBB.15 variant
Versus the XBB.15 variant
The European Commission has approved the third update of the prophylactic, used under the trade name of ‘Comirnaty’.
The European Commission has given the go-ahead to the adaptation of the BionTech-Pfizer vaccine against the new coronavirus subvariant omicron XBB.1. Photo: EUROPEAN UNION.
2023-09-02 08:22:12
#Free #Europe #adaptation #Pfizer #vaccine #covid
Related posts:
Understanding Lung Cancer: Symptoms, Causes, and Prevention to Raise Awareness and Save Lives
The Health Benefits and Properties of Kaki Fruit: A Guide to Eating and Enjoying this Fruit of the G...
Neurologist from Indonesia Presents at International Alzheimer's Conference in Amsterdam
"Flu shots in the US to exclude Yamagata strain, driven by Covid-19"
